October 28, 2025 - 03:34

In a significant move to bolster Canada’s defense capabilities, a leading aerospace company has acquired an advanced suite of modular dual-use defense assets. This acquisition is expected to support not only Canada's sovereign defense requirements but also meet the needs of allied nations across the globe. The newly acquired technology boasts near-term commercialization potential, positioning the company to capitalize on emerging market opportunities.
This strategic acquisition is synergistic with the company's recently announced Mirabel Innovation and Manufacturing Centre, which aims to foster innovation and enhance production capabilities. The integration of these dual-use unmanned aerial systems (UAS) into the company's existing product portfolio will allow for the mass production of various strategic UAS models.
With a focus on both defense and commercial applications, this development marks a pivotal moment for the aerospace sector in Canada, as it seeks to strengthen its position in the global defense landscape while ensuring readiness for future challenges.
August 4, 2026 - 19:37
When Tech Outpaces the Pentagon's Buying PowerThe gap between how fast private industry develops new technology and how quickly the government can buy it is getting wider, and that mismatch is creating real problems for national defense....
August 4, 2026 - 03:37
Idaho, Utah among finalists for nuclear waste, nuclear technology sitesFederal officials have narrowed the list of potential locations for a major nuclear waste management and technology complex, and both Idaho and Utah are still in the running. The chosen campuses...
August 3, 2026 - 01:31
Credo Technology Stock (CRDO) Opinions on AI Infrastructure ExpansionRecent discussions among investors and industry watchers have shifted focus to Credo Technology and its role in the rapidly expanding AI data center market. The conversation centers on the...
August 2, 2026 - 00:47
FDA weighs a new kind of flu shot based on technology RFK Jr. has questionedThe Food and Drug Administration is nearing a decision on a new type of influenza vaccine developed by Moderna, one that uses the same messenger RNA platform behind the company`s COVID-19 shots. If...